Lightnews — Scholar-powered news

dyadams.bsky.social @dyadams.bsky.social · 26d

Looking forward to reading this

dyadams.bsky.social @dyadams.bsky.social · 26d

Passed PhD viva (minor corrections) Rewarding experience discussing research on deprescribing psychotropic medicines in people with intellectual disabilities. Thank you examiners Rohit Shankar and Hayley Crawford, and supervisors @peterlangdon.bsky.social @profhastings.bsky.social Ian Maidment.

1 1 2

dyadams.bsky.social @dyadams.bsky.social · Aug 20

Now published open access www.frontiersin.org/journals/psy...

1

dyadams.bsky.social @dyadams.bsky.social · Aug 4

Delighted to share that my final PhD study has been provisionally accepted in Frontiers in Psychiatry
www.frontiersin.org/journals/psy...
Thank you to co-authors
@peterlangdon.bsky.social @profhastings.bsky.social & ian maidment

Full paper to follow soon.

Frontiers | Factors supporting optimisation of psychotropic deprescribing in people with intellectual disabilities within the UK: a modified Delphi Study

Overprescribing psychotropic medication for people with intellectual disabilities increases the risk of adverse effects and has prompted deprescribing initia...

www.frontiersin.org

1 2

dyadams.bsky.social @dyadams.bsky.social · Jun 26

Study looking at pharmacists' perspectives of psychotropic deprescribing in people with intellectual disabilities published open access. @peterlangdon.bsky.social @profhastings.bsky.social professor ian maidment & Dr. Olivia hewitt.
#deprescribing #pharmacists
www.tandfonline.com/doi/full/10....

Pharmacists’ Perspectives on Deprescribing Psychotropic Medicines in People with Intellectual Disabilities

Psychotropic medicines are sometimes inappropriately prescribed for individuals with intellectual disabilities without a clinical diagnosis of a mental illness, increasing risks of side effects and...

www.tandfonline.com

2 2

dyadams.bsky.social @dyadams.bsky.social · Jan 23

Pleased to share that our opinion piece on Psychotropic deprescribing in ethnic minority individuals with a learning disability
has been published in the Pharmaceutical Journal. A big thank you to my co author Dr Hassan Mahmood
pharmaceutical-journal.com/article/opin...

Psychotropic deprescribing in ethnic minority individuals with a learning disability requires a more nuanced approach

Health inequalities are pervasive across our healthcare system, affecting different patients in different ways and requiring an increasingly nuanced approach to tackle them. For individuals from an et...

pharmaceutical-journal.com

1 1 5

dyadams.bsky.social @dyadams.bsky.social · Dec 14

Had a brilliant couple of days in London at the Seattle Club Conference. Great range of oral and poster presentations, focus on inclusive research and addressing health inequalities in people with intellectual disabilities. Thank you to Deborah Chinn, Rory Sheehan and rest of organising team

1 4

dyadams.bsky.social @dyadams.bsky.social · Dec 14

Delighted to have been at the Seattle Club Conference in London with Priyanka Chaudhuri presenting the SMILE project poster scoping review looking at issues related to medication use for people with intellectual disabilities and interventions to address them.

5

Reposted

Silvana Mengoni @silvanamengoni.bsky.social · Dec 12

Holly is looking for speech and language therapists to take part in her research about accessible health information @healthlibraryholly.bsky.social

2 15 15

dyadams.bsky.social @dyadams.bsky.social · Dec 14

Had a great couple of days at Seattle Club Conference in London. Delighted to be able to share the outcomes of study looking at pharmacists perspectives on psychotropic deprescribing in people with intellectual disabilities

SHINE Lab @shinelab.bsky.social · Dec 13

The next talk in our session on mental health at medication at #seattleclub is with PhD student Danielle Adams from the University of Warwick. Her talk looks at pharmacists' perspectives on de-prescribing psychotropic medicines in people with intellectual disabilities.

2